BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Drug Information Association Begins Transition to New Executive Leadership


12/5/2012 2:52:15 PM

DECEMBER 5, 2012, HORSHAM, PA, USA — DIA today announced that Worldwide Executive Director Paul Pomerantz will be leaving effective March 3, 2013, to assume the position of CEO for the American Society of Anesthesiologists. In the next three months, Mr. Pomerantz will work closely with DIA’s Board of Directors to execute a smooth transition that sustains the momentum the organization has achieved under his leadership.

“Paul has been an extraordinary executive director who will be sorely missed, but together we have built a strong foundation for continued growth,” said DIA President Dr. Ling Su. “We are committed to continuing the implementation of our strategic plan, which is bringing quality programs and services to our members and stakeholders globally. We thank Paul for his contributions and wish him the best of success in his new position.”

Under the leadership of Mr. Pomerantz, DIA has achieved rapid global expansion and significantly increased its stakeholder relationships—particularly among global health organizations, regulatory agencies and patient groups—driving its transformation into a world-class, knowledge-driven organization.

“This was a very difficult decision to make,” Mr. Pomerantz said. “The last three years have been among the most fulfilling of my professional career. I am proud of what we accomplished, and confident that DIA’s Board of Directors, staff and volunteers will continue our progress. My new position provides an exciting challenge to serve the needs of a leading medical association and its patients.”

The DIA Board of Directors will announce plans for the executive director search in January.

ABOUT DIA

DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and lifecycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C.; and Latin America.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->